Connor, Clark & Lunn Investment Management (CC&L)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Buy |
|
|||||
|
2025
Q1 | $16.4M | Buy |
|
|||||
|
2024
Q4 | $13.8M | Buy |
|
|||||
|
2024
Q3 | $2.08M | Sell |
|
|||||
|
2024
Q2 | $2.53M | Sell |
|
|||||
|
2024
Q1 | $15.8M | Sell |
|
|||||
|
2023
Q4 | $22.6M | Buy |
|
|||||
|
2023
Q3 | $22.8M | Sell |
|
|||||
|
2023
Q2 | $29.6M | Buy |
|
|||||
|
2023
Q1 | $33.1M | Buy |
|
|||||
|
2022
Q4 | $33.9M | Buy |
|
|||||
|
2022
Q3 | $16.4M | Buy |
|
|||||
|
2022
Q2 | $13.7M | Buy |
|
|||||
|
2022
Q1 | $10.3M | Sell |
|
|||||
|
2021
Q4 | $9.74M | Buy |
|
|||||
|
2021
Q3 | $5.32M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $503K | Sell |
|
|||||
|
2019
Q1 | $847K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $265K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2.19M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $868K | Sell |
|
|||||
|
2014
Q3 | $4.05M | Sell |
|
|||||
|
2014
Q2 | $4.21M | Sell |
|
|||||
|
2014
Q1 | $6.78M | Buy |
|
|||||
|
2013
Q4 | $1.14M | Buy |
|